Skip to content
RDL Network logo
TCT-304 Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan — Shinichiro Masuda (2022) | RDL Network